Spinal Cord Injury Induces Lesional Expression of the Proinflammatory and Antiangiogenic Cytokine EMAP II

Journal of Neurotrauma

Volumn 20, Issue 10, 2003, Pages 1007-1015

  Mueller, Christian Andreas ^a   Schluesener, Hermann J ^a   Conrad, Sabine ^a   Meyermann, Richard ^a   Schwab, Jan M ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Anti angiogenic; Bystander damage; EMAP II; Inflammation; Secondary damage

Indexed keywords

CYTOKINE; ENDOTHELIAL MONOCYTE ACTIVATING POLYPEPTIDE II;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CONTROLLED STUDY; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MACROPHAGE; MALE; MICROGLIA; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; RAT; SPINAL CORD INJURY;

EID: 0142057429     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/089771503770195858     Document Type: Article

References (41)

1. BARTHOLDI, D., and SCHWAB, M.E. (1997). Expression of pro-inflammatory cytokine and chemokine mRNA upon experimental spinal cord injury in mouse, an in situ hybridization study. Eur. J. Neurosci. 9, 1422-1438.
2. BERGER, A.C., ALEXANDER, H.R., TANG, G., et al. (2000). Endothelial monocyte activating polypeptide II induces endothelial cell apoptosis and may inhibit tumor angiogenesis. Microvasc. Res. 60, 70-80.
3. BLIGHT, A.R. (1985). Delayed demyelination and macrophage invasion: a candidate for secondary cell damage in spinal cord injury. CNS Trauma 2, 299-315.
4. BLIGHT, A.R. (1992). Macrophages and inflammatory damage in spinal cord injury. J. Neurotrauma 9, Suppl. 1, 83-91.
5. CARLOS, T.M., and HARLAN, J.M. (1994). Leucocyte-endothelial adhesion molecules. Blood 84, 2068-2101.
6. CHANG, S.Y., PARK, S.G., KIM, S., et al. (2002). Interaction of the C-terminal domain of p43 and the alpha subunit of ATP-Synthetase. Its functional implication in endothelial cell proliferation. J. Biol. Chem. 277, 8388-8394.
7. CHAO, C.C., HU, S., MOLITOR, T.W., et al. (1992). Activated microglia mediate neuronal cell injury via nitric oxide mechanism. J. Immunol. 149, 2736-2741.
8. DAVID, S., BOUCHARD, C., TSATAS, O., et al. (1990). Macrophages can modify the nonpermissive nature of the adult mammalian central nervous system. Neuron 5, 463-469.
9. DUSART, I., and SCHWAB, M.E. (1994). Secondary cell death and the inflammatory reaction after dorsal hemisection of the rat spinal cord. Eur. J. Neurosci. 6, 712-724.
10. ESIRI, M.M., and GAY, D. (1990). Immunological and neuropathological significance of the Virchow-Robin space. J. Neurol. Sci. 100, 3-8.
11. FERRARIO, A., von THIEL, K.F., RUCKER, N., et al. (2000). Antiangiogenetic treatment enhances photodynamic therapy reponsiveness in a mouse mammary carcinoma. Cancer Res. 60, 4066-4069.
12. GIULIAN, D., CHEN J., INGEMAN, J.E., et al. (1989). The role of mononuclear phagocytes in wound healing after traumatic injury to adult mammalian brain. J. Neurosci. 9, 4416-4429.
13. GOODMAN, J.C., ROBERTSON, C.S., GROSSMAN, R.G., et al. (1990). Elevation of tumor necrosis factor in head injury. J. Neuroimmunol. 30, 213-217.
14. HSU, C.Y., HU Z.Y., and DOSTER, S.K. (1996) Cell-mediated injury, in: Neurotrauma. R.K. Narayan, J.E. Wilberger, and J.T. Povlishock (eds), McGraw-Hill: New York, pps. 1433-1444.
15. IMPERATO-KALMAR, E.L., McKINNEY, R.A., SCHNELL, L., et al. (1997). Local changes in vascular architecture following partial spinal cord lesion in rat. Exp. Neurol. 145, 322-328.
16. KAO, J., RYAN, J., BRETT, G., et al. (1992). Endothelial monocyte-activating polypeptide II. A novel tumor-derived polypeptide that activates host-response mechanisms. J. Biol. Chem. 267, 20239-20247.
17. KAO, J., FAN, Y.C., HAEHNEL, I., et al. (1994a). A peptide derived from the amino terminus of endothelial-monocyte-activating polypeptide II modulates mononuclear and polymorphonuclear leukocyte functions, defines an apparently novel cellular interaction site, and induces an acute inflammatory response. J. Biol. Chem. 269, 9774-9782.
18. KAO, J., HOUCK, K., FAN, Y., et al. (1994b). Characterization of a novel tumor-derived cytokine. Endothelial-monocyte activating polypeptide II. J. Biol. Chem. 269, 25106-25119.
19. KATO, H., and WALZ, W. (2000). The initiation of the microglial response. Brain Pathol. 10, 137-143.
20. KNIES, U.E., BEHRENSDORF, H.A., MITCHELL, C.A., et al. (1998). Regulation of endothelial monocyte-activating polypeptide II release by apoptosis. Proc. Natl. Acad. Sci. USA 95, 12322-12327.
21. LU, X., and RICHARDSON, P.M. (1991). Inflammation near nerve cell body enhances axonal regeneration. J. Neurosci. 11, 972-978.
22. MADRI, J.A., SANKAR S., and ROMANIC, A.M. (1996). Angiogenesis, in: The Molecular and Cellular Biology of Wound Repair. R.A.F. Clark (ed), Plenum: New York, pps. 355-371.
23. McCLAIN, C., COHEN, D., PHILLIPS, R., et al. (1991). Increased plasma and ventricular fluid interleukin-6 levels in patients with head injury. J. Lab. Clin. Med. 118, 225-231.
24. MERKLER, D., METZ, G.A., RAINETEAU, O., et al., (2001). Locomotor recovery in spinal cord-injured rats treated with an antibody neutralizing the myelin-associated neurite growth inhibitor Nogo-A. J. Neurosci. 21, 3665-3673.
25. MULLIN, J.M., and SNOCK, K.V. (1990). Effect of tumor necrosis factor on epithelial tight junctions and transepithelial permeability. Cancer Res 50, 2172-2176.
26. MURRAY, J.C., BARNETT, G., TAS, M., et al. (2000). Immunohistochemical analysis of endothelial-monocyte-activating polypeptide-II expression in vivo. Am. J. Pathol. 157, 2045-2053.
27. OTT, L., McCLAIN, C.J., GILLESPIE, M., et al. (1994). Cytokines and metabolic dysfunction after severe head injury. J. Neurotrauma 11, 447-472.
28. PIANI, D., FREI, K., DO, K.Q., et al. (1991). Murine brain macrophages induce NMDA receptor mediated neurotoxicity in vitro by secreting glutamate. Neurosci. Lett. 133, 159-162.
29. POPOVICH, P.G., STREIT, W.J., and STOKES, B.T. (1997). Differential expression of MHC class II antigen in the contused rat spinal cord. J. Neurotrauma 10, 37-46.
30. POPOVICH, P.G., WEI P., and STOKES, B.T. (1997). Cellular inflammatory response after spinal cord injury in the Sprague-Dawley and Lewis rats. J. Comp. Neurol. 377, 443-464.
31. QUAGLIARELLO, V.J., WISPELWEY, B., LONG, W.J., JR., et al. (1991). Recombinant human interleukin-1 induces meningitis and blood-brain barrier injury in the rat. Characterization and comparison with tumor necrosis factor. J. Clin. Invest. 87, 1360-1366.
32. RAPALINO, O., LAZAROV-SPIEGLER, O., AGRANOV, E., et al. (1998). Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats. Nat. Med. 4, 814-821.
33. SCHLUESENER, H.J., SEID, K., ZHAO, Y., et al. (1997). Localization of endothelial-monocyte-activating polypeptide (EMAP II), a novel proinflammatory cytokine, to lesions of experimental autoimmune encephalomyelitis, neuritis and uveitis: expression by monocytes and activated microglial cells. Glia 20, 365-372.
34. SCHLUESENER, H.J., SEID, K., KRETZSCHMAR J., et al. (1998). Allograft inflammatory factor-1 in rat experimental autoimmune encephalomyelitis, neuritis, and uveitis: expression by activated macrophages and microglial cells. Glia 24, 244-251.
35. SCHNELL, L., FEARN, S., SCHWAB, M.E., et al. (1999). Cytokine-induced acute inflammation in the brain and spinal cord. J. Neuropathol. Exp. Neurol. 58, 245-254.
36. SCHWAB, J.M., FREI, E., KLUSMAN, I., et al. (2001). AIF-1 expression defines a proliferating and alert microglial/macrophage phenotype following spinal cord injury in rats. J. Neuroimmunol. 119, 214-222, 2001
37. STREIT, W.J., WALTER, S.A., and Pennell, N.A. (1999). Reactive microgliosis. Prog. Neurobiol. 57, 563-581.
38. TAS, M.P., and MURRAY, J.C. (1996). Endothelial-monocyte-activating polypeptide II. Int. J. Biochem. Cell. Biol. 28, 837-841.
39. TATOR, C.H. (1995). Update on the pathophysiology and pathology of acute spinal cord injury. Brain Pathol. 5, 407-413.
40. TERADA, L.S., WILLLINGHAM, I.R., GUIDOT, D.M., et al. (1992). Tungsten treatment prevents tumor necrosis factor-induced injury of brain endothelial cells. Inflammation 16, 13-19.
41. ZHENG, M., SCHWARZ, M.A., LEE, S., et al. (2001). Control of stromal keratitis by inhibition of neovascularization. Am. J. Pathol. 159, 1021-1029.